Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

People can seek to lose weight for many reasons, all of them personal — but for celebrities, these journeys become public, as ...

Obesity is in the news because of a new weight-loss drug in the form of a pill that can be taken any time of day, with or ...

Forget the gruelling gym workouts and strict diets. In Nairobi, a diabetes drug is all the rage for quick weight loss, but is ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

The hidden drawbacks of using weight loss jabs - Mounjaro and Ozempic can be game changers, but they can come with a cost ...